Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Garovoy

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Transplant Immunology|September 1, 1995
The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantationJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|April 1, 1993
OKT3 antibody response study: comparative testing of human antimouse antibodyJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|February 1, 1993
OKT3 antibody response study (OARS): a multicenter comparative studyJ A Kimball, D J Norman, C F Shield, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2007
A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantationF Vincenti, R Mendez, M Pescovitz, et al.
Journal of the American Academy of Dermatology|February 25, 2000
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasisA Gottlieb, J G Krueger, R Bright, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Transplant Immunology|September 1, 1995
The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantationJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|April 1, 1993
OKT3 antibody response study: comparative testing of human antimouse antibodyJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|February 1, 1993
OKT3 antibody response study (OARS): a multicenter comparative studyJ A Kimball, D J Norman, C F Shield, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2007
A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantationF Vincenti, R Mendez, M Pescovitz, et al.
Journal of the American Academy of Dermatology|February 25, 2000
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasisA Gottlieb, J G Krueger, R Bright, et al.
Pageof 4